Dr Wise’s move is yet more evidence of the Institute’s ability to develop sought-after scientific talent, the Director says. “It’s a testament to HRI’s commitment to developing and supporting top talent, that Steve has been able to progress in this manner.”
Dr Wise’s recent funding success, including NHMRC project, NHMRC development and ARC Linkage grants, demonstrates the quality of his research program and has laid the foundations for his move to USYD.
Dr Wise also won high praise for a recent project completed under the mentorship of HRI’s senior research team. The work to develop new synthetic conduits for arterial revascularisation received the 2018 NHMRC Marshall and Warren Award recognising the most innovative project that could change the way a disease is diagnosed, treated or prevented.
While Dr Wise will no longer be based at HRI in Eliza Street, he will not be lost to the Camperdown research precinct, or to HRI research teams. “He will continue to collaborate with other HRI Groups, including Dr Anna Waterhouse on their two joint research grants,” Professor Jackson says.
